We are live on
!
Find out more
FLAM
First Light Asset Management Portfolio holdings
AUM
$1.12B
1-Year Est. Return
114.45%
This Fund
S&P 500
This Quarter
Est. Return
-12.67%
1 Year Est. Return
+114.45%
3 Year Est. Return
+266.49%
5 Year Est. Return
+454.92%
10 Year Est. Return
+8,470.94%
AUM
$586M
AUM Growth
-$197M
(-25%)
Cap. Flow
-$56.9M
Cap. Flow
% of AUM
-9.71%
Top 10 Holdings %
Top 10 Hldgs %
50.11%
Holding
80
New
11
Increased
14
Reduced
24
Closed
16
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPNE
SeaSpine Holdings Corporation Common Stock
SPNE
|
+$35.1M |
| 2 |
PFNX
Pfenex Inc.
PFNX
|
+$25.7M |
| 3 |
CareDx
CDNA
|
+$24.3M |
| 4 |
Iovance Biotherapeutics
IOVA
|
+$14.1M |
| 5 |
IMMU
Immunomedics Inc
IMMU
|
+$13M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Omnicell
OMCL
|
+$37.1M |
| 2 |
MODN
MODEL N, INC.
MODN
|
+$30.2M |
| 3 |
MYOK
MyoKardia, Inc. Common Stock
MYOK
|
+$26.4M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
+$24.1M |
| 5 |
NeoGenomics
NEO
|
+$21.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 77.23% |
| 2 | Communication Services | 3.51% |
| 3 | Industrials | 1.19% |
| 4 | Energy | 0.34% |
| 5 | Financials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TRHC
26
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
| $7M | 1.19% |
133,858
-75,831
| -36% | -$4.11M |
|
|
MYOK
27
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $5.63M | 0.96% |
120,095
-411,789
| -77% | -$26.4M |
|
28
Veracyte
VCYT
$3.7B
| $5.44M | 0.93% |
223,722
-185,355
| -45% | -$4.67M |
|
29
Vertex Pharmaceuticals
VRTX
$121B
| $5.43M | 0.93% |
22,828
-3,689
| -14% | -$846K |
|
30
QuidelOrtho
QDEL
$1.14B
| $5.23M | 0.89% |
53,512
-631
| -1% | -$51K |
|
31
Zymeworks
ZYME
$1.61B
| $5.14M | 0.88% |
+144,909
| New | +$5.93M |
|
32
Bio-Techne
TECH
$11.2B
| $4.81M | 0.82% |
101,424
-10,988
| -10% | -$550K |
|
33
OrthoPediatrics
KIDS
$519M
| $4.77M | 0.81% |
120,234
-1,280
| -1% | -$57.4K |
|
34
Simulations Plus
SLP
$369M
| $4.31M | 0.74% |
123,303
-1,315
| -1% | -$43.9K |
|
|
BLUE
35
DELISTED
bluebird bio
BLUE
| $4.23M | 0.72% |
7,106
+2,120
| +43% | +$2.07M |
|
|
ARNA
36
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $3.92M | 0.67% |
93,329
-92,399
| -50% | -$4.24M |
|
37
Ligand Pharmaceuticals
LGND
$5.76B
| $3.26M | 0.56% |
71,909
+2,206
| +3% | +$125K |
|
|
AMRN
38
Amarin Corp
AMRN
$298M
| $3.03M | 0.52% |
37,895
+14,981
| +65% | +$4.98M |
|
|
EPZM
39
DELISTED
Epizyme, Inc
EPZM
| $3.03M | 0.52% |
195,160
-2,083
| -1% | -$44.7K |
|
40
Glaukos
GKOS
$9.83B
| $2.79M | 0.48% |
+90,565
| New | +$4.65M |
|
|
ADVM
41
DELISTED
Adverum Biotechnologies
ADVM
| $2.37M | 0.4% |
+24,230
| New | +$2.83M |
|
|
LHCG
42
DELISTED
LHC Group LLC
LHCG
| $2.02M | 0.34% |
14,393
-38,829
| -73% | -$5.41M |
|
43
iShares Biotechnology ETF
IBB
$9.34B
| $1.8M | 0.31% |
16,713
-4,535
| -21% | -$522K |
|
44
Invesco S&P SmallCap Health Care ETF
PSCH
$163M
| $1.79M | 0.31% |
51,855
| – | – |
|
45
State Street Health Care Select Sector SPDR ETF
XLV
$41.9B
| $1.62M | 0.28% |
18,241
| – | – |
|
46
LeMaitre Vascular
LMAT
$2.32B
| $1.2M | 0.2% |
48,129
-513
| -1% | -$15.8K |
|
|
ITMR
47
DELISTED
Itamar Medical Ltd. American Depository Shares
ITMR
| $960K | 0.16% |
+81,500
| New | +$1.11M |
|
|
GBT
48
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $577K | 0.1% |
11,300
-2,700
| -19% | -$181K |
|
|
GWPH
49
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $560K | 0.1% |
+6,400
| New | +$678K |
|
50
Centene
CNC
$30.7B
| $530K | 0.09% |
+8,917
| New | +$541K |
|
Similar funds
AIM
MTCM
CNC
C
RIM
CT
SL
HH
First Light Asset Management's Q1 2020 Portfolio in Review
As of Q1 2020, First Light Asset Management held 80 positions worth $586M, down 25% from $782M the previous quarter. Its ten largest holdings account for 50% of the portfolio.
First Light Asset Management withdrew a net $56.9M in Q1 2020, closing 16 positions and reducing 24 holdings. Its most notable exit was Omnicell, an estimated $37.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 77% of assets, up from 73% a quarter earlier, followed by Communication Services and Industrials.
Against the trend, First Light Asset Management opened a new position in Pfenex Inc. worth $20.6M.
- First Light Asset Management's largest Q1 2020 buy was Pfenex Inc.: 2,339,671 shares worth $20.6M.
- First Light Asset Management added most to SeaSpine Holdings Corporation Common Stock in Q1 2020, an estimated $35.1M increase.
- First Light Asset Management's biggest Q1 2020 reduction was MODEL N, INC., cutting an estimated $30.2M.
- First Light Asset Management fully exited Omnicell in Q1 2020, selling an estimated $37.1M.
- First Light Asset Management's ten largest holdings make up 50% of its $586M portfolio in Q1 2020.
- First Light Asset Management opened 11 new positions and closed 16 in Q1 2020.
- First Light Asset Management's portfolio value fell 25% quarter-over-quarter to $586M.
Based on First Light Asset Management's 13F filing for Q1 2020, filed 15 May 2020.